PMID- 15703445 OWN - NLM STAT- MEDLINE DCOM- 20050809 LR - 20210217 IS - 1535-9476 (Print) IS - 1535-9476 (Linking) VI - 4 IP - 5 DP - 2005 May TI - Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. PG - 618-25 AB - The substantial complexity and vast dynamic range of protein abundance in biological fluids, notably serum and plasma, present a formidable challenge for comprehensive protein analysis. Integration of multiple technologies is required to achieve high-resolution and high-sensitivity proteomics analysis of biological fluids. We have implemented an orthogonal three-dimensional intact-protein analysis system (IPAS), coupled with protein tagging and immunodepletion of abundant proteins, to quantitatively profile the human plasma proteome. Following immunodepletion, plasma proteins in each of paired samples are concentrated and labeled with a different Cy dye, before mixing. Proteins are subsequently separated in three dimensions according to their charge, hydrophobicity, and molecular mass. Differences in the abundance of resolved proteins are determined based on Cy dye ratios. We have applied this strategy to profile the plasma proteome for changes that occur with acute graft-versus-host disease (GVHD), following allogeneic bone marrow transplantation (BMT). Using capillary HPLC ESI Q-TOF MS, we identified 75 proteins in the micromolar to femtomolar range that exhibited quantitative differences between the pre- and post-GVHD samples. These proteins included serum amyloid A, apolipoproteins A-I/A-IV, and complement C3 that are well-known acute-phase reactants likely reflecting the post-BMT inflammatory state. In addition, we identified some potentially interesting immunologically relevant molecules including vitamin D-binding protein, fetuin, vitronectin, proline-rich protein 3 and 4, integrin-alpha, and leukocyte antigen CD97. IPAS provides a combination of comprehensive profiling and quantitative analysis, with a substantial dynamic range, for disease-related applications. FAU - Wang, Hong AU - Wang H AD - Department of Pediatrics, University of Michigan, Ann Arbor, Michigan 48109, USA. FAU - Clouthier, Shawn G AU - Clouthier SG FAU - Galchev, Vladimir AU - Galchev V FAU - Misek, David E AU - Misek DE FAU - Duffner, Ulrich AU - Duffner U FAU - Min, Chang-Ki AU - Min CK FAU - Zhao, Rong AU - Zhao R FAU - Tra, John AU - Tra J FAU - Omenn, Gilbert S AU - Omenn GS FAU - Ferrara, James L M AU - Ferrara JL FAU - Hanash, Samir M AU - Hanash SM LA - eng PT - Comparative Study PT - Journal Article DEP - 20050209 PL - United States TA - Mol Cell Proteomics JT - Molecular & cellular proteomics : MCP JID - 101125647 RN - 0 (Blood Proteins) RN - 0 (Proteome) SB - IM MH - Adult MH - Antibody Affinity MH - Blood Proteins/*analysis/chemistry/immunology MH - *Bone Marrow Transplantation MH - Chromatography, Affinity/*methods MH - Chromatography, High Pressure Liquid MH - Electrophoresis, Gel, Two-Dimensional MH - Graft vs Host Disease/*blood/therapy MH - Humans MH - Plasma/chemistry/immunology MH - Proteome/*analysis/immunology MH - Reproducibility of Results MH - Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization MH - *Transplantation Conditioning EDAT- 2005/02/11 09:00 MHDA- 2005/08/10 09:00 CRDT- 2005/02/11 09:00 PHST- 2005/02/11 09:00 [pubmed] PHST- 2005/08/10 09:00 [medline] PHST- 2005/02/11 09:00 [entrez] AID - S1535-9476(20)31487-0 [pii] AID - 10.1074/mcp.M400126-MCP200 [doi] PST - ppublish SO - Mol Cell Proteomics. 2005 May;4(5):618-25. doi: 10.1074/mcp.M400126-MCP200. Epub 2005 Feb 9.